1. Mate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral Etiology
   Ge Gao et al, 2015, Viruses CrossRef
2. Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management
   Julie Vendrell et al, 2017, IJMS CrossRef
3. null
   Bryce Portier, 2018 CrossRef
4. Exploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assay
   Sanpeng Xu et al, 2016 CrossRef
5. Comparative analysis of Adam33 mutations in murine lung cancer cell lines by droplet digital PCR, real-time PCR and Insight Onco™ NGS
   Soo-Jin Kim et al, 2018, Mol. Cell. Toxicol. CrossRef
6. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma
   Sharna Tanzima Nuhat et al, 2018, Cancer Sci CrossRef
7. Detection of circulating Mycobacterium tuberculosis-specific DNA by droplet digital PCR for vaccine evaluation in challenged monkeys and TB diagnosis
   Neng Song et al, 2018, Emerg Microbes Infect CrossRef
8. Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types
   Toshiyuki Ishiba et al, 2018, Biochemical and Biophysical Research Communications CrossRef
9. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring
   Jillian Wilhelmina Paulina Bracht et al, 2018, Curr Oncol Rep CrossRef
10. Multiplex real-time PCR assay combined with rolling circle amplification (MPRP) using universal primers for non-invasive detection of tumor-related mutations
    Jian Gong et al, 2018, RSC Adv. CrossRef
11. Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis
    Linyan Chen et al, 2018, Gene CrossRef
12. Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms.
    Kobus J Bosman et al, 2018, J Int AIDS Soc CrossRef
13. A digital PCR assay development to detect EGFR T790M mutation in NSCLC patients
    Ruifeng Zhou et al, 2018, Frontiers in Laboratory Medicine CrossRef
14. Case report: primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation
    Lin-Peng Zheng et al, 2018, BMC Cancer CrossRef
15. Circulating Aflatoxin B1-Related TP53 Mutation Detected by Digital PCR in Tunisian Patients with and Without Hepatocellular Carcinoma
    Agnes Marchio et al, 2019, Hepat Mon CrossRef
16. Sensitive detection of low-abundance in-frame deletions in EGFR exon 19 using novel wild-type blockers in real-time PCR
    Xiao-Dong Ren et al, 2019, Sci Rep CrossRef
17. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
    Jee‐Soo Lee et al, 2019, Mol Oncol CrossRef
18. A new primer construction technique that effectively increases amplification of rare mutant templates in samples
    Jr-Kai Huang et al, 2019, BMC Biotechnol CrossRef
19. Droplet digital PCR-aided screening and characterization ofPichia pastorismultiple gene copy strains
    Elena Cámara et al, 2016, Biotechnol. Bioeng. CrossRef
20. Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.
    Jian Zhou et al, 2016, J Gastrointest Cancer CrossRef
21. EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: a validation study
    Umberto Malapelle et al, 2016, J Clin Pathol CrossRef
22. EGFR Testing in Advanced Non–Small-Cell Lung Cancer, A Mini-Review
    Yuri Sheikine et al, 2016, Clinical Lung Cancer CrossRef
23. Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs
    Chengjuan Zhang et al, 2017, PLoS ONE CrossRef
24. Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Gabriella Cirmena et al, 2020, Journal of Oncology CrossRef
25. ctDNA Detection in Microfluidic Platform: A Promising Biomarker for Personalized Cancer Chemotherapy
    Samla Gauri et al, 2020, Journal of Sensors CrossRef
26. KRAS Mutations in Papillary Fibroelastomas
    Melanie C. Bois et al, 2020, The American Journal of Surgical Pathology CrossRef
27. Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas
    Sameer A. Dhayat et al, 2020, J Cancer Res Clin Oncol CrossRef
28. Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)
    Ji Yun Lee et al, 2016, Oncotarget CrossRef
29. Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer
    Xuefei Li et al, 2017, Oncotarget CrossRef
30. Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology
    Shirong Zhang et al, 2016, Oncotarget CrossRef
31. Technical challenges in the isolation and analysis of circulating tumor cells
    Emma E. van der Toom et al, 2016, Oncotarget CrossRef
32. Detection of Low-level EGFR c.2369 C > T (p.Thr790Met) Resistance Mutation in Pre-treatment Non-small Cell Lung Carcinomas Harboring Activating EGFR Mutations and Correlation with Clinical Outcomes
    Linda Ye et al, 2020, Pathol. Oncol. Res. CrossRef
33. A novel ARMS-based assay for the quantification of EGFR mutations in patients with lung adenocarcinoma.
    Yazhen Zhu et al, 2018, Oncol Lett CrossRef
34. Circulating tumor DNA detection: A potential tool for colorectal cancer management (Review)
    Huizi Li et al, 2018, Oncol Lett CrossRef
35. A Self-Priming Digital Polymerase Chain Reaction Chip for Multiplex Genetic Analysis
    Juxin Yin et al, 2020, ACS Nano CrossRef
36. dPCR vs. qPCR: The role of Poisson statistics at low concentrations
    Joel Tellinghuisen, 2020, Analytical Biochemistry CrossRef
37. null
    Lukas Bubendorf et al, 2020 CrossRef
38. Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients
    Uršula Prosenc Zmrzljak et al, 2021, Genes CrossRef
39. The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A systematic review and meta-analysis
    Peng Ye et al, 2021, PLoS ONE CrossRef
40. Quantitative analysis of cell-free DNA by droplet digital PCR reveals the presence of EGFR mutations in non-malignant lung pathologies
    Rajesh Venkataram et al, 2021, Monaldi Arch Chest Dis CrossRef
41. Application of the conventional and novel methods in testing EGFR variants for NSCLC patients in the last 10 years through different regions: a systematic review
    Jasmina Obradovic et al, 2021, Mol Biol Rep CrossRef
42. Detection of PIK3CA Gene Mutation in Head and Neck Squamous Cell Carcinoma Using Droplet Digital PCR and RT-qPCR
    Edyta M. Borkowska et al, 2021, Biomolecules CrossRef
43. The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies
    A. Russo et al, 2021, ESMO Open CrossRef
44. Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma
    Valerio Gristina et al, 2021, JMP CrossRef
45. Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening
    Jacob J. Adashek et al, 2021, Cancers CrossRef
46. Disrupting the LINC complex by AAV mediated gene transduction prevents progression of Lamin induced cardiomyopathy
    Ruth Jinfen Chai et al, 2021, Nat Commun CrossRef
47. Simultaneous quantitation of 3ADON and 15ADON chemotypes of DON-producing Fusarium species in Chinese wheat based on duplex droplet digital PCR assay
    Song Shan Wang et al, 2021, Journal of Microbiological Methods CrossRef
48. Introduction of Noninvasive Prenatal Testing for Blood Group and Platelet Antigens from Cell-Free Plasma DNA Using Digital PCR
    Marion Eryilmaz et al, 2020, Transfus Med Hemother CrossRef
49. Recent Advances in Device Engineering and Computational Analysis for Characterization of Cell-Released Cancer Biomarkers
    Hesam Abouali et al, 2022, Cancers CrossRef
50. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
    Hui Zhou et al, 2022, Mol Cancer CrossRef
51. The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer
    Sara Memarpour et al, 2021, CCDT CrossRef
52. Multivariate Risk Analysis of RAS, BRAF and EGFR Mutations Allelic Frequency and Coexistence as Colorectal Cancer Predictive Biomarkers
    Adriana Ionescu et al, 2022, Cancers CrossRef
53. null
    Alexandra Teixeira et al, 2022 CrossRef
54. A direct and multiplex digital PCR chip for EGFR mutation
    Juxin Yin et al, 2022, Talanta CrossRef
55. Diagnostic and prognostic biomarkers in colorectal cancer and the potential role of exosomes in drug delivery
    Real Sumayya Abdul Sattar et al, 2022, Cellular Signalling CrossRef
56. Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients
    Javier Simarro et al, 2022, IJMS CrossRef
57. Detection of clinically-relevant EGFR variations in de novo small cell lung carcinoma by droplet digital PCR
    Rajesh Venkataram et al, 2022, Monaldi Arch Chest Dis CrossRef
58. Liquid biopsy: current technology and clinical applications
    Mina Nikanjam et al, 2022, J Hematol Oncol CrossRef
59. “SMART” digital nucleic acid amplification technologies for lung cancer monitoring from early to advanced stages
    Yulin Ren et al, 2022, TrAC Trends in Analytical Chemistry CrossRef
60. Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell products
    Lindsey A. Murphy et al, 2022, Cytotherapy CrossRef
61. null
    E. Capoluongo et al, 2023 CrossRef
62. Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients
    Hui Zhang et al, 2023, Front. Oncol. CrossRef
63. null
    Emilis Gegevicius et al, 2020 CrossRef
64. Liquid Biopsies, Novel Approaches and Future Directions
    Athanasios Armakolas et al, 2023, Cancers CrossRef
65. Soo-PCR: Single Nucleotide Variant On-Off Discrimination – Polymerase Chain Reaction
    Juny Shin et al, 2022, SSRN Journal CrossRef
66. Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based IdyllaTM System
    Youssra Boustany et al, 2023, Cancer Control CrossRef
67. Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent Surgery
    Ankit Dhiman et al, 2023 CrossRef
68. Clinical application of circulating tumor DNA in metastatic cancers
    Negin Raei et al, 2023, Expert Review of Molecular Diagnostics CrossRef
69. Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker
    Li Li et al, 2023, Cancer Cell Int CrossRef
70. The dynamic variation position and predominant quasispecies of hepatitis B virus: Novel predictors of early hepatocarcinoma
    Chaojun Zhang et al, 2024, Virus Research CrossRef
71. Liquid Biopsy: A Game Changer for Type 2 Diabetes
    Gratiela Gradisteanu Pircalabioru et al, 2024, IJMS CrossRef
72. Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies
    Valentina Giudice et al, 2024, Clin Exp Med CrossRef